MicroFlow® Micronucleus Test

MNT Featured

MicroFlow® Micronucleus Test

The Microflow® in vitro micronucleus test is used to detect structural or numerical changes to chromosomes in cells exposed to test article.

GTX Logo + MF-MNT logoChromosomal damage is detected by the presence of micronuclei in the cytoplasm of interphase cells that originate from acentric fragments, or whole chromosomes that failed to segregate correctly during anaphase.This means the MNT is sensitive to both clastogenic and aneugenic mechanisms of genotoxicity*.

Diagram of formation of Micronuclei

Recently, enumeration of micronuclei has been automated by the use of high-content image analysis and flow cytometry platforms. Whilst these detection platforms are not yet adopted for use in regulatory versions of the in vitro MNT, they are frequently used in pre-regulatory testing regimes and in early development, hazard identification screening approaches.

Micronucleus Test at Gentronix

Gentronix currently offers the MicroFlow® flow cytometric MNT developed by Litron Laboratories as a part of our genotoxicity testing service. This method utilises a dual-labelling approach to allow automated, flow cytometric enumeration of micronuclei from TK6 cells, exposed to test chemical in the absence or presence of metabolic activation using S9 fraction.

Gentronix micronucleus testing services provides our clients with:

  • Automated, higher throughput scoring than microscopy based methods.
  • Collection of 10,000 nucleated events per dose.
  • Discrimination between micronuclei and chromatin from apoptotic/necrotic cells.
  • Low test chemical requirement.

* Parry, J., Parry, E., Bourner, R., Doherty, A., Ellard, S., O’Donovan, J., Hoebee, B., et al. (1996) The detection and evaluation of aneugenic chemicals. Mutation Research, 353: 11-46.